A Perihilar Variant of Focal Segmental Glomerulosclerosis Due to <i>De novo</i> Branchio-oto-renal Syndrome

  • Saiki Ryosuke
    Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan
  • Katayama Kan
    Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan
  • Kitano Masako
    Department of Otorhinolaryngology-Head & Neck Surgery, Mie University Graduate School of Medicine, Japan
  • Tsujimoto Kayo
    Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan
  • Tanaka Fumika
    Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan
  • Suzuki Yasuo
    Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan
  • Murata Tomohiro
    Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan
  • Kurita Tairo
    Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan
  • Okamoto Ryuji
    Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan
  • Takeuchi Kazuhiko
    Department of Otorhinolaryngology-Head & Neck Surgery, Mie University Graduate School of Medicine, Japan
  • Dohi Kaoru
    Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan

Search this article

Description

<p>Branchio-oto-renal syndrome is an autosomal dominant disorder characterized by branchial anomalies, hearing loss, and renal urinary tract malformations. We herein report a 32-year-old Japanese man with a right preauricular pit, bilateral mixed hearing loss, and malposition of the right kidney who presented with proteinuria. The findings of a left kidney biopsy were compatible with a perihilar variant of secondary focal segmental glomerular sclerosis. A trio exome analysis conducted among the patient and his parents failed to identify the causal gene variant, despite a sporadic pattern. His kidney function remained stable for 11 years with an angiotensin II receptor blocker. </p>

Journal

  • Internal Medicine

    Internal Medicine 61 (13), 2033-2038, 2022-07-01

    The Japanese Society of Internal Medicine

References(11)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top